Literature DB >> 18159499

Antimicrobial resistance - Judicious use is the key.

John M Conly1.   

Abstract

Year:  2004        PMID： 18159499      PMCID： PMC2094982          DOI： 10.1155/2004/680349

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN： 1712-9532            Impact factor:   2.471


× No keyword cloud information.
  24 in total

Review 1.  Spread of vancomycin-resistant enterococci: why did it happen in the United States?

Authors:  W J Martone
Journal:  Infect Control Hosp Epidemiol       Date:  1998-08       Impact factor: 3.254

Review 2.  Antibiotic resistance: an ecological imbalance.

Authors:  S B Levy
Journal:  Ciba Found Symp       Date:  1997

Review 3.  Inactivation of antibiotics and the dissemination of resistance genes.

Authors:  J Davies
Journal:  Science       Date:  1994-04-15       Impact factor: 47.728

Review 4.  The sleeping giant. Antimicrobial resistance.

Authors:  J M Casellas; M G Blanco; M E Pinto
Journal:  Infect Dis Clin North Am       Date:  1994-03       Impact factor: 5.982

5.  A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group.

Authors:  G G Zhanel; J A Karlowsky; G K Harding; A Carrie; T Mazzulli; D E Low; D J Hoban
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

6.  Uropathogen antibiotic resistance in adult women presenting to family physicians with acute uncomplicated cystitis.

Authors:  Warren J McIsaac; Tony Mazzulli; Rahim Moineddin; Janet Raboud; Susan Ross
Journal:  Can J Infect Dis Med Microbiol       Date:  2004-09       Impact factor: 2.471

7.  Nosocomial enterococci resistant to vancomycin--United States, 1989-1993.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1993-08-06       Impact factor: 17.586

8.  Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002.

Authors:  George G Zhanel; Lorraine Palatnick; Kimberly A Nichol; Tracy Bellyou; Don E Low; Daryl J Hoban
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

9.  Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991.

Authors:  A L Panlilio; D H Culver; R P Gaynes; S Banerjee; T S Henderson; J S Tolson; W J Martone
Journal:  Infect Control Hosp Epidemiol       Date:  1992-10       Impact factor: 3.254

10.  Ambler class A extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals.

Authors:  Michael R Mulvey; Elizabeth Bryce; David Boyd; Marianna Ofner-Agostini; Sara Christianson; Andrew E Simor; Shirley Paton
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191
View more
  3 in total

1.  Unexpected insights into antibacterial activity of zinc oxide nanoparticles against methicillin resistant Staphylococcus aureus (MRSA).

Authors:  Usha Kadiyala; Emine Sumeyra Turali-Emre; Joong Hwan Bahng; Nicholas A Kotov; J Scott VanEpps
Journal:  Nanoscale       Date:  2018-03-08       Impact factor: 7.790

Review 2.  New antibiotic agents in the pipeline and how they can help overcome microbial resistance.

Authors:  Ian M Gould; Abhijit M Bal
Journal:  Virulence       Date:  2013-01-09       Impact factor: 5.882

Review 3.  Macromolecular Conjugate and Biological Carrier Approaches for the Targeted Delivery of Antibiotics.

Authors:  Nhan Dai Thien Tram; Pui Lai Rachel Ee
Journal:  Antibiotics (Basel)       Date:  2017-07-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.